Maria-Luisa Maccecchini - 20 Oct 2022 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Role
Director
Signature
/s/ Maria-Luisa Maccecchini
Issuer symbol
LTRN
Transactions as of
20 Oct 2022
Net transactions value
$0
Form type
4
Filing time
24 Oct 2022, 17:57:08 UTC
Previous filing
17 Jun 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LTRN Stock Option (Right to Buy) Award $0 +3,200 $0.000000 3,200 20 Oct 2022 Common Stock 3,200 $4.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option is granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. 356 shares of the Option vested on the day of grant, with the remaining Option shares to vest in equal monthly installments commencing November 8, 2022 with last vesting on June 8, 2025.